A new experimental treatment is bringing hope to those who suffer from a rare disease that makes daily walking and moving difficult.

It’s about rigid syndrome, a disease that causes muscle rigidity, and strong, painful spasms. Because of it, some patients also have serious difficulties in performing normal activities.

Mayo CIA researchers in the United States have tested a new treatment called CAR-T, which uses the patient’s own protective cells to combat the processes that cause the disease.

The first results have been encouraging. Some patients have shown improvements in movement and everyday life.

One of them has been able to get back to work, while another patient has regained the ability to walk the course.

This treatment functions by taking some cells from the patient’s blood, processing them into the laboratory, and then turning them into an organism to help the immune system fight the disease.

However, doctors stress that treatment is still in the study phase, and further research is needed to prove its security and its long – term effects.

Despite this, the results are considered a promising development and a new prospect of hope for those living with this rare disease.

Source Layer: Dukeagini